期刊文献+

舒弗美缓释片对严重慢性阻塞性肺疾病患者峰值呼气流速的影响 被引量:1

Effect of Therophylline Slow-Releasing Pill on Severe Chronic Obstructive Pulmonary Disease Patients' Peak Expiratory Flow Rate
暂未订购
导出
摘要 目的:了解舒弗美缓释片对严重慢性阻塞性肺疾病的疗效。方法:对20例COPD患者使用舒弗美缓释片每日二次,每次200mg口服,连续治疗4周。结果:治疗后峰值呼气流速(peakexpiratoryflowrate,PEFR)比治疗前明显好转。治疗时间越长,改善越明显。医患双方时临床疗效评价的有效率分别为85%、80%。结论:使用舒弗美缓释片治疗COPD有良好的疗效。 Objective:To explore the effect of theophylline slow-releasing pill on chronic obstructive pulmonary disease (COPD). Methods:Twenty patients were giver: therphylline slow releasing pill(200mg,bid) for 4 weeks continuously. Results:The peak expiratory flow rate(PEFR) was improved significantly after treatment, the effect was more significant than others when being treated for longer time. The valuable evaluation of doctors and patients to the drug were 85% and 80% respectively. Conclusion: There is a good effect to use theophylline slow-releasing pill to treat COPD.
出处 《沈阳医学院学报》 2005年第1期25-26,共2页 Journal of Shenyang Medical College
关键词 峰值呼气流速 慢性阻塞性肺疾病患者 缓释片 舒弗美 严重慢性阻塞性肺疾病 COPD患者 临床疗效评价 连续治疗 rate 治疗时间 医患双方 治疗后 治疗前 有效率 theophylline slow-releasing pill peak expiratory flow rate(PEFR) chronic obstructive pnlmonary disease (COPD)
  • 相关文献

参考文献7

  • 1Nowak Rm, Pensier MI, Sarkar DD,et al. Comparison of peak expiratory flow and FEV1 admission eritheria for acute bronchial asthma[J]. Ann Emerg Med,1992,23(11 ) :64 -69.
  • 2Emerman CL,Cydnlka RK. Use of peak expiratory flow rate in emergency department evaluation of exacerbation of chronic obstructive pulmonary disease[ J]. Ann Emerg Med,1996,27(2) :159 -162.
  • 3慢性阻塞性肺疾病诊治指南[J].中华结核和呼吸杂志,2002,25(8):453-460. 被引量:5091
  • 4Martin RJ. The sleep-related worsening of lower airways obstruction understanding and intervention [ J ]. Med Clin North Am, 1998, 74:701 - 706.
  • 5Goldenheim PD, Schein LK. Chronotherapy of reversible airways disease with once-daily evening doses of a controlled-release theophylline preparation [ J ]. Ann NY Acad Sci, 1998, 2:490 - 496.
  • 6崔德健.支气管哮喘治疗的进展[J].中华结核和呼吸杂志,2004,27(7):474-476. 被引量:33
  • 7Hill NS. The use of theophylline in irreversible chronic obstructive pulmonary disease [ J ]. Arch Intern Med, 1998,158:3579 - 3581.

二级参考文献11

  • 1Barnes PJ. Scientific rationale for inhaled combination therapy with long-acting beta2-agonists and corticosteroids. Eur Respir J, 2002,19:182-191.
  • 2Campbell LM. From adrenaline to formoterol: advances in beta-agonist therapy in the treatment of asthma. Int J Clin Pract, 2002,56: 783-790.
  • 3Rees PJ. Tiotropium in the management of chronic obstructive pulmonary disease. Eur Respir J, 2002,19: 205-206.
  • 4Hansel TT, Barnes PJ. Novel drugs for treating asthma. Curr Allergy Asthma Rep, 2001,1: 164-173.
  • 5Owen CE. Anti-immunoglobulin E therapy for asthma. Pulm Pharmacol & Ther, 2002,15: 417-424.
  • 6Hansel TT. New treatments for asthma: current and future aspects. Curr Opin Pulm Med, 2001,7 Suppl 1:S3-S6.
  • 7Andre C, Vatrinet C, Galvain S, et al. Safety of sublingual-swallow immunotherapy in children and adults. Int Arch Allergy Immunol, 2000, 121: 229-234.
  • 8郭雪君 见: 黄绍光 主编.哮喘的基因治疗[A].见: 黄绍光,主编.肺内科新进展[C].北京:人民卫生出版社,2000.94-101.
  • 9沈华浩,朱元珏.哮喘免疫治疗的新进展[J].中华结核和呼吸杂志,2000,23(1):55-56. 被引量:38
  • 10郭克泰.过敏原免疫疗法的现状[J].国外医学(呼吸系统分册),2001,21(3):157-160. 被引量:1

共引文献5122

同被引文献6

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部